Association between the presence of CD15 (0–3), CD15+MPO+ (0, 1), or CD15+MPO− (0, 1) tumor-infiltrating cells, and clinical and immunological parameters in primary breast cancer. The gene discussed is MPO; the disease is breast cancer.